tesamorelin or retatrutide Peptide Vs Tesamorelin vs. Retatrutide: Comparing Visceral

Each full dose contains 10 mg of retatrutide, with a total of 40 mg active ingredient in the pen

Seven large-scale trials are running

doi: 10.1001/jama.2016.10260

Retatrutide In early-phase trials, Retatrutide showed substantial weight loss (up to 24.2% over 48 weeks)

While both GLP-1 medications and Ozempic help with weight management by promoting satiety (feeling of fullness) and reducing food intake, there are some key differences: Composition: Ozempic (semaglutide GLP-1) is a specific GLP-1 receptor agonist, while GLP-1 refers to a broader category of drugs that includes medications like Wegovy (another semaglutide GLP-1 formulation), tirzepatide, and others

TRIUMPH-4 also tested a 9mg dose, and additional trials are evaluating a 4mg maintenance dose